Vaccines

Health By Lauran Neergaard — Associated Press

FDA clears Covid booster shot for healthy kids ages 5 to 11

Health By Rachel Cohrs

What happens when the government stops buying Covid-19 vaccines?

Pharmalot By Ed Silverman

National Institutes of Health licenses nearly a dozen Covid-19 technologies to a WHO program

Politics By Lev Facher

Dr. Oz peddles medical misinformation — but could his political rise have a silver lining for public health?

Pharmalot By Ed Silverman

A compromise on patent waivers for Covid-19 vaccines takes a key step at the WTO

Pharmalot By Ed Silverman

U.N. committee urges wealthy nations to honor human rights and widen access to Covid vaccines

Pharmalot By Ed Silverman

Pharmalittle: Investors reject proposals for Covid vaccine makers to share know-how; CMS head says Alzheimer’s drug decision is rare

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: How cancer-killing cell therapies work, biotech’s endless downturn, & an FDA conundrum

Health By Lauran Neergaard — Associated Press

Moderna seeks to be first with Covid shots for children younger than 6

Pharmalot By Ed Silverman

Pharmalittle: Amgen faces $7B IRS back-tax bill and fine; McKinsey exec apologizes for opioid work during hearing

Health By Megan Molteni

Covid’s circling the White House. What are the risks to someone like Biden? 

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: An ominous biotech deal, vaccines for kids, & ‘breakthrough’ devices

First Opinion By Dawn Sinclair Shapiro

Men and women may respond differently to vaccines. Research needs to account for that

Health By Helen Branswell

Kizzmekia Corbett on the pandemic, public service, and her path to becoming a scientist

First Opinion By Dinesh Thakur

India’s drug regulator has ignored red alerts on Covaxin, imperiling millions of lives

Health By Lauran Neergaard — Associated Press

Pfizer to seek Covid booster for healthy 5- to 11-year-olds

First Opinion By Christopher M. Worsham and Anupam B. Jena

The ‘successful failures’ of Apollo 13 and Covid-19 vaccination

The Readout LOUD By Adam Feuerstein and Meg Tirrell

Listen: What’s next for Roche, a debate over second boosters, & Vertex’s recent success

Health By Andrew Joseph and Matthew Herper

Tracking an FDA advisory panel meeting on Covid-19 vaccines and boosters

First Opinion By Rebecca Weintraub, Benjy Renton and David C. Grabowski

Narrowing the vaccine gap as boosters begin for people over 50

Politics By Rachel Cohrs

Senate nears $10 billion deal to buy Covid vaccines, therapeutics

Health By Andrew Joseph

U.S. approves second Covid-19 booster for people 50 and older

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Helen Branswell on the evolving pandemic, plus the next FDA debate and the perks of being a CEO

First Opinion By John P. Moore and Luciana L. Borio

Covid-19 vaccine policy should be made by public health experts, not company executives

Health By Helen Branswell

The Covid-19 vaccine market is getting crowded — as demand begins to wane